Institutional shares held 109 Million
130K calls
245K puts
Total value of holdings $4.59B
$5.45M calls
$10.3M puts
Market Cap $6.24B
148,138,000 Shares Out.
Institutional ownership 73.6%
# of Institutions 433


Latest Institutional Activity in BRKR

Top Purchases

Q2 2025
Wealth Enhancement Advisory Services, LLC Shares Held: 40.5K ($1.7M)
Q2 2025
Sivia Capital Partners, LLC Shares Held: 7.21K ($304K)
Q2 2025
North Crest Asset Manangement, LLC Shares Held: 6.41K ($270K)
Q2 2025
Pallas Capital Advisors LLC Shares Held: 9.5M ($400M)
Q2 2025
Massmutual Trust CO Fsb Shares Held: 1.92K ($80.7K)

Top Sells

Q2 2025
Diversified Trust CO Shares Held: 5.66K ($238K)
Q2 2025
Farther Finance Advisors, LLC Shares Held: 270 ($11.4K)
Q1 2025
Alyeska Investment Group, L.P. Shares Held: 325K ($13.7M)
Q1 2025
Td Asset Management Inc Shares Held: 778K ($32.8M)
Q1 2025
Massachusetts Financial Services CO Shares Held: 2.4M ($101M)

About BRKR

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.


Insider Transactions at BRKR

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
289K Shares
From 22 Insiders
Grant, award, or other acquisition 118K shares
Open market or private purchase 123K shares
Exercise of conversion of derivative security 47.5K shares
Sell / Disposition
33.7K Shares
From 5 Insiders
Payment of exercise price or tax liability 25.7K shares
Open market or private sale 8.03K shares

Track Institutional and Insider Activities on BRKR

Follow BRUKER CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BRKR shares.

Notify only if

Insider Trading

Get notified when an Bruker Corp insider buys or sells BRKR shares.

Notify only if

News

Receive news related to BRUKER CORP

Track Activities on BRKR